Share

April 18, 2017; 88 (16 Supplement) April 27, 2017

Therapeutic Effect of KPT-350 in a Preclinical Model of Duchenne Muscular Dystrophy (S42.003)

Devin Gibbs, Rylie Hightower, Christopher Lee, Janelle Spinazzola, Lillian Mead, Jeffrey Widrick, Sharon Tamir, Shelton Cochran, Yosef Landesman, Louis Kunkel, Matthew Alexander
First published April 17, 2017,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 88 no. 16 Supplement S42.003
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 17, 2017.
Copyright & Usage: 
© 2017

Author Disclosures

    1. Devin Gibbs1,
    2. Rylie Hightower2,
    3. Christopher Lee1,
    4. Janelle Spinazzola1,
    5. Lillian Mead1,
    6. Jeffrey Widrick1,
    7. Sharon Tamir3,
    8. Shelton Cochran3,
    9. Yosef Landesman3,
    10. Louis Kunkel1 and
    11. Matthew Alexander4
  1. Devin Gibbs1,
  2. Rylie Hightower2,
  3. Christopher Lee1,
  4. Janelle Spinazzola1,
  5. Lillian Mead1,
  6. Jeffrey Widrick1,
  7. Sharon Tamir3,
  8. Shelton Cochran3,
  9. Yosef Landesman3,
  10. Louis Kunkel1 and
  11. Matthew Alexander4
  1. 1Division of Genetics and Genomics, Boston Children’s Hospital and Harvard Medical School Boston MA United States
  2. 2University of Alabama at Birmingham Graduate School of Biomedical Sciences Birmingham AL United States
  3. 3Karyopharm Therapeutics Newton MA United States
  4. 4Department of Pediatrics, Division of Neurology at Children’s of Alabama and the University of Alabama at Birmingham Birmingham AL United States

Article usage

Article usage: April 2017 to December 2022

AbstractFullPdfSource
Apr 20172800Highwire
May 20176900Highwire
Jun 20171900Highwire
Jul 20171400Highwire
Aug 20171600Highwire
Sep 20171200Highwire
Oct 20171400Highwire
Nov 2017600Highwire
Dec 20172000Highwire
Jan 20183300Highwire
Feb 20181400Highwire
Mar 20181900Highwire
Apr 2018800Highwire
May 2018700Highwire
Jun 20181100Highwire
Jul 20181500Highwire
Aug 20181200Highwire
Sep 20181400Highwire
Oct 20181800Highwire
Nov 20182100Highwire
Dec 20182300Highwire
Jan 20195400Highwire
Feb 20193600Highwire
Mar 20192400Highwire
Apr 20193700Highwire
May 20192200Highwire
Jun 20191300Highwire
Jul 2019700Highwire
Aug 20191100Highwire
Sep 20191300Highwire
Oct 2019400Highwire
Nov 20191300Highwire
Dec 2019500Highwire
Jan 20201300Highwire
Feb 2020600Highwire
Mar 20201100Highwire
Apr 20201000Highwire
May 20201100Highwire
Jun 20201400Highwire
Jul 20201800Highwire
Aug 20202000Highwire
Sep 20202000Highwire
Oct 20202800Highwire
Nov 20202200Highwire
Dec 20201700Highwire
Jan 20211800Highwire
Feb 20212400Highwire
Mar 20212200Highwire
Apr 20212600Highwire
May 20212600Highwire
Jun 20212600Highwire
Jul 2021400Highwire
Aug 2021600Highwire
Sep 2021200Highwire
Oct 2021100Highwire
Nov 2021200Highwire
Dec 2021300Highwire
Jan 2022200Highwire
Feb 2022600Highwire
Mar 2022200Highwire
Apr 2022400Highwire
May 2022300Highwire
Jun 2022200Highwire
Jul 2022800Highwire
Aug 2022300Highwire
Sep 2022300Highwire
Oct 2022300Highwire
Nov 2022400Highwire
Dec 2022200Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me